Immune System Diseases
Information
- Disease name
- Immune System Diseases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03562975 | Active, not recruiting | Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus | July 23, 2018 | December 2023 | |
| NCT06107348 | Active, not recruiting | COVID-19 Post-Vaccination Observation | July 1, 2021 | December 24, 2023 | |
| NCT04309084 | Active, not recruiting | Phase 1 | Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma | May 12, 2020 | April 30, 2023 |
| NCT05445284 | Active, not recruiting | N/A | Group Education Trial to Improve Transition for Parents of Adolescents With T1D | October 10, 2023 | March 2026 |
| NCT05516758 | Active, not recruiting | Phase 2 | A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis | August 31, 2022 | January 23, 2025 |
| NCT04663204 | Active, not recruiting | Phase 2 | A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy | December 10, 2020 | March 31, 2025 |
| NCT02663297 | Active, not recruiting | Phase 1 | Administration of T Lymphocytes for Prevention of Relapse of Lymphomas | July 15, 2016 | January 2037 |
| NCT06353035 | Active, not recruiting | N/A | Biodiversity Interventions for Well-Being | March 30, 2022 | September 30, 2027 |
| NCT01222039 | Completed | Phase 1/Phase 2 | Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease. | June 2010 | June 2014 |
| NCT01328548 | Completed | Zoster Vaccine Response in the Frail Elderly | May 2011 | March 2015 | |
| NCT01425073 | Completed | N/A | Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya | February 2012 | October 2013 |
| NCT01441076 | Completed | Phase 1/Phase 2 | Anakinra for Behcet s Disease | September 2011 | November 2014 |
| NCT01472263 | Completed | Phase 3 | Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases | September 2009 | September 2012 |
| NCT01490177 | Completed | Phase 1 | Single Center Food Allergy Oral Immunotherapy Study | November 2011 | April 2014 |
| NCT01510626 | Completed | Phase 1 | Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center | November 2011 | December 2015 |
| NCT01727973 | Completed | Phase 1/Phase 2 | Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy | October 2012 | November 2013 |
| NCT01764594 | Completed | Phase 1 | Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus | January 2013 | August 2014 |
| NCT01917760 | Completed | Pharmacokinetics Study of Gamma-aminobutyric Acid | July 2013 | December 2014 | |
| NCT02119143 | Completed | N/A | Micronutrient Supplementation and Incidence of Common Cold | April 2014 | February 2017 |
| NCT02162576 | Completed | N/A | Asthma Data Innovation Demonstration Project | June 2012 | January 2014 |
| NCT02294552 | Completed | Phase 2 | Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT | October 2014 | November 2017 |
| NCT02331446 | Completed | N/A | The Effect of Different Volumes of Physical Exercise on the Immune System | March 2014 | September 2014 |
| NCT02527122 | Completed | N/A | Biological Stardadization of D. Pteronyssinus and D. Farinae Allergen Extracts | July 21, 2016 | August 2018 |
| NCT02527187 | Completed | Phase 2 | Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa | September 2015 | November 2016 |
| NCT05210530 | Completed | Phase 1 | An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1D | January 24, 2022 | January 19, 2023 |
| NCT04977739 | Completed | Research on the Application and Mechanism of New Biological Probes in Biomedicine | August 3, 2021 | July 25, 2022 | |
| NCT02630082 | Completed | N/A | Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru | April 2011 | March 2013 |
| NCT04837651 | Completed | Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab | March 2, 2021 | July 1, 2021 | |
| NCT02644759 | Completed | Phase 1/Phase 2 | Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus | February 2014 | May 2018 |
| NCT04790201 | Completed | N/A | Friendship Bench Adaptation to Improve Mental Health & HIV Care Engagement Outcomes Among PLWH and PWID in Vietnam | February 28, 2022 | July 31, 2023 |
| NCT02824393 | Completed | Early Phase 1 | Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria | March 3, 2017 | July 15, 2018 |
| NCT02916888 | Completed | A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists | September 2016 | December 2017 | |
| NCT02966301 | Completed | Phase 2 | Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide | December 2016 | June 2020 |
| NCT03161288 | Completed | Phase 1 | A Study of KY1005 in Healthy Volunteers | May 29, 2017 | March 30, 2018 |
| NCT03199638 | Completed | N/A | Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes | April 1, 2016 | June 30, 2017 |
| NCT04653376 | Completed | Relationship of Endoplasmic Reticulum Stress and Tonsillar Tissue Diseases | November 1, 2018 | June 10, 2019 | |
| NCT03337165 | Completed | Phase 1 | Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis | December 2016 | August 2019 |
| NCT04502940 | Completed | Is Lymphocyte Subtype Important for Acute Pancreatitis Severity? | June 1, 2020 | April 29, 2021 | |
| NCT03345004 | Completed | Phase 2 | Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes | December 20, 2017 | April 27, 2021 |
| NCT04449939 | Completed | Phase 1 | A Study of Subcutaneous KY1005 in Healthy Volunteers | July 7, 2020 | November 30, 2020 |
| NCT03503747 | Completed | Investigating Genetic Risk for Type 1 Diabetes | April 25, 2018 | August 31, 2021 | |
| NCT03563066 | Completed | Phase 2 | Effect of Benralizumab in Atopic Dermatitis | September 4, 2018 | September 28, 2021 |
| NCT04103099 | Completed | N/A | Impact of HLNatural Immune Supplement on Colds | October 16, 2019 | August 15, 2020 |
| NCT03997175 | Completed | N/A | Effect of Modified Playground Environment on Health, Particularly Immune System | April 15, 2018 | July 30, 2018 |
| NCT03627767 | Completed | Phase 3 | Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects | June 11, 2018 | October 7, 2020 |
| NCT03922087 | Completed | No-worry Baby Project | November 20, 2018 | September 30, 2023 | |
| NCT03688074 | Completed | Phase 2 | Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE) | November 2, 2018 | November 16, 2020 |
| NCT03720470 | Completed | Phase 3 | Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy | October 29, 2018 | March 6, 2020 |
| NCT00113464 | Completed | Developing Newborn Screening for Infants With Primary Immunodeficiency | June 2, 2005 | April 13, 2007 | |
| NCT00119548 | Completed | N/A | Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling | March 2005 | January 2007 |
| NCT06286839 | Completed | N/A | Study of Cannabidiol (CBD) in Healthy Volunteers | May 12, 2022 | December 14, 2022 |
| NCT01056471 | Completed | Phase 1/Phase 2 | Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis | January 2010 | June 2015 |
| NCT01090102 | Completed | Phase 4 | Mesalamine to Reduce T Cell Activation in HIV Infection | June 2010 | December 2012 |
| NCT01093911 | Completed | Phase 1 | Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) | March 2010 | December 2012 |
| NCT01161056 | Completed | Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways | May 2009 | April 2015 | |
| NCT03594162 | No longer available | Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch | |||
| NCT05969821 | Not yet recruiting | Clonal Hematopoiesis of Immunological Significance | September 2023 | September 2043 | |
| NCT05910840 | Not yet recruiting | N/A | Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care | November 1, 2023 | June 1, 2027 |
| NCT05616117 | Not yet recruiting | Next-generation Effects of Vitamin D Supplementation in Pregnancy | November 2022 | November 2024 | |
| NCT06173544 | Not yet recruiting | N/A | HIV Engagement and Adolescent Depression Support (HEADS-UP) | July 2024 | April 2025 |
| NCT06353087 | Not yet recruiting | Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) | April 1, 2024 | November 15, 2025 | |
| NCT06069583 | Not yet recruiting | N/A | Implementation of Support in the Care of Adults Living With Type 1 Diabetes | January 5, 2024 | January 5, 2028 |
| NCT04339777 | Recruiting | Phase 2 | Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity | September 22, 2020 | November 30, 2027 |
| NCT04656873 | Recruiting | Immuno-Oncology Database and Bioregistry | May 20, 2021 | April 2031 | |
| NCT03016377 | Recruiting | Phase 1/Phase 2 | Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL | March 22, 2012 | April 22, 2041 |
| NCT02690545 | Recruiting | Phase 1/Phase 2 | Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL | August 26, 2016 | August 26, 2040 |
| NCT06271252 | Recruiting | Phase 1 | A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study | April 3, 2024 | April 12, 2028 |
| NCT03672318 | Recruiting | Phase 1 | Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma | January 14, 2019 | June 2028 |
| NCT03663933 | Recruiting | Phase 2 | Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation | September 4, 2018 | January 1, 2031 |
| NCT03922724 | Recruiting | Phase 2 | Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma | April 18, 2019 | June 30, 2029 |
| NCT03602157 | Recruiting | Phase 1 | Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL | December 12, 2018 | September 30, 2041 |
| NCT00001406 | Recruiting | Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia | April 21, 1997 | ||
| NCT05509075 | Recruiting | Nutraceuticals and Functional Foods | November 12, 2019 | November 29, 2023 | |
| NCT05565248 | Recruiting | Phase 1/Phase 2 | An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D | January 20, 2023 | August 2025 |
| NCT05621317 | Recruiting | Phase 2 | A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy | February 9, 2023 | July 2025 |
| NCT05726461 | Recruiting | N/A | Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in China | February 11, 2023 | September 30, 2024 |
| NCT05787574 | Recruiting | Phase 2 | A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition | March 15, 2023 | March 2027 |
| NCT05792176 | Recruiting | N/A | Ukulele Playing to Improve Cognition in People With Multiple Sclerosis: A Feasibility Study | March 27, 2023 | August 1, 2025 |
| NCT05928585 | Recruiting | Phase 1 | A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers | July 6, 2023 | April 2024 |
| NCT06065592 | Recruiting | Phase 1 | Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms | February 1, 2019 | December 2024 |
| NCT06104111 | Recruiting | Phase 1 | Epigenetic Memory of Vitamin D Supplementation | October 1, 2023 | March 30, 2025 |
| NCT03696784 | Recruiting | Phase 1 | Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma | March 12, 2019 | March 22, 2043 |
| NCT06272370 | Recruiting | Phase 4 | Individualizing Treatment for Asthma in Primary Care | February 1, 2024 | September 30, 2024 |
| NCT06291415 | Recruiting | Phase 1 | The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) | April 2, 2024 | November 2026 |
| NCT00006150 | Recruiting | Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES) | August 10, 2000 | ||
| NCT02579967 | Recruiting | Phase 2 | Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies | November 19, 2015 | December 21, 2028 |
| NCT05414890 | Recruiting | Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination | June 30, 2022 | June 30, 2024 | |
| NCT04642066 | Suspended | N/A | Cold Water Immersion and Atherosclerosis, Inflammation, Fat Accumulation and Lipid Profile Parameters | October 25, 2018 | June 30, 2026 |
| NCT00260299 | Terminated | Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency | February 2005 | January 31, 2016 | |
| NCT02535052 | Unknown status | Investigating the Immune System in chrONIC Kidney Disease. | July 2015 | ||
| NCT02203682 | Unknown status | Phase 2 | Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy | July 2014 | July 2022 |
| NCT04319705 | Unknown status | Phase 4 | Anti-viral Effects of Azithromycin in Patients With Asthma and COPD | March 2, 2020 | December 31, 2022 |
| NCT01579110 | Unknown status | Phase 2 | Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. | April 2012 | April 2016 |
| NCT03344094 | Unknown status | Mechanism of Action of Ocrelizumab in Multiple Sclerosis | October 12, 2017 | December 31, 2019 | |
| NCT03578341 | Unknown status | Phase 3 | Oral Colostrum and Its Effect on Immune System | June 1, 2018 | December 31, 2019 |
| NCT01319643 | Unknown status | Phase 4 | Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU) | December 2009 | November 2011 |
| NCT03373019 | Unknown status | Phase 2 | Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) | December 21, 2017 | March 1, 2021 |
| NCT02640014 | Unknown status | N/A | Oral Immunotherapy in Food Allergy in Finland | December 2015 | December 2021 |
| NCT03311074 | Withdrawn | Phase 4 | Retroviral Insertion Site Methodology Study | June 25, 2020 | July 9, 2020 |
| NCT05431179 | Withdrawn | Phase 3 | A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma | March 2023 | December 2026 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D007154